ASHLEY WEBB: Open Payments
NPI 1194375329 · FUQUAY VARINA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 41 payments from 13 companies in 2025. Trend: 2023 $674 · 2024 $865 · 2025 $908
Food & beverage: $908
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 12 | $239 |
| Madrigal Pharmaceuticals | 5 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| ABBVIE INC. | 5 | $92 |
| PFIZER INC. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Intercept Pharmaceuticals, Inc. | 2 | $44 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Braintree Laboratories, Inc. | 1 | $25 |
Products named: IBSRELA, REZDIFFRA, ENTYVIO, DUPIXENT, VELSIPITY, OCALIVA, ZENPEP, RINVOQ.
Industry payments across NC — which companies pay providers there.
